Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Pertuzumab – Treatment / Therapy for Breast Cancer

Drug (Brand / Generic)

Perjerta / Pertuzumab

Company / Licensee

Roche / Genentech

Therapy Class

HER dimerisation inhibitor (HDI)

Product Description

Inhibits dimerisation of the HER2 protein with other members of the HER family of receptors

Current Indication

Breast cancer

Market Sector

Oncology

Development Status

Approved in the US
Expand

Go Top